Pliant Therapeutics (PLRX) Accounts Payables (2019 - 2025)
Historic Accounts Payables for Pliant Therapeutics (PLRX) over the last 7 years, with Q3 2025 value amounting to $485000.0.
- Pliant Therapeutics' Accounts Payables fell 9296.08% to $485000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $485000.0, marking a year-over-year decrease of 9296.08%. This contributed to the annual value of $6.0 million for FY2024, which is 3153.83% up from last year.
- As of Q3 2025, Pliant Therapeutics' Accounts Payables stood at $485000.0, which was down 9296.08% from $1.4 million recorded in Q2 2025.
- Pliant Therapeutics' 5-year Accounts Payables high stood at $7.3 million for Q1 2024, and its period low was $485000.0 during Q3 2025.
- Moreover, its 5-year median value for Accounts Payables was $3.1 million (2022), whereas its average is $3.5 million.
- In the last 5 years, Pliant Therapeutics' Accounts Payables skyrocketed by 41634.95% in 2024 and then plummeted by 9296.08% in 2025.
- Quarter analysis of 5 years shows Pliant Therapeutics' Accounts Payables stood at $3.0 million in 2021, then plummeted by 46.82% to $1.6 million in 2022, then soared by 186.77% to $4.5 million in 2023, then skyrocketed by 31.54% to $6.0 million in 2024, then tumbled by 91.86% to $485000.0 in 2025.
- Its last three reported values are $485000.0 in Q3 2025, $1.4 million for Q2 2025, and $5.6 million during Q1 2025.